This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
TWi Pharmaceuticals, Inc.
Drug Names(s): AC-201, Diacerein, Diacetylrhein
Description: AC-201 is an orally potent small molecule that modulate the transcriptional cytokine synthesis of IL-1ß (reduces) and IL-1RA (increases). Reduction of IL-1ß has been demonstrated to be effective in treating a variety of inflammatory diseases including Arthritis, Diabetic Nephropathy (DN) and Diabetic Mellitus (DM).
Additional information available to subscribers only: